- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 99-113 of
153 results
1010 Exhibit: Ex 1010 Day 2 Jan 14, 2020 Trial Transcript from Amarin Pharma, Inc...
Document
IPR2022-00215, No. 1010 Exhibit - Ex 1010 Day 2 Jan 14, 2020 Trial Transcript from Amarin Pharma, Inc v Hikma Pharms USA Inc, No 16 2525 D Nev Testimony of Dr Budoff (P.T.A.B. Nov. 30, ...
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 7
Document
IPR2022-00215, No. 1013-7 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 7 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 1
Document
IPR2022-00215, No. 1013 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 1 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 6
Document
IPR2022-00215, No. 1013-6 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 6 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 5
Document
IPR2022-00215, No. 1013-5 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 5 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 9
Document
IPR2022-00215, No. 1013-9 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 9 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 8
Document
IPR2022-00215, No. 1013-8 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 8 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1009 Exhibit: Ex 1009 Plaintiffs Corrected Post Trial Proposed Findings of Fact and...
Document
IPR2022-00215, No. 1009 Exhibit - Ex 1009 Plaintiffs Corrected Post Trial Proposed Findings of Fact and Conclusions of Law Feb 27, 2020 from Amarin Pharma, Inc v Hikma Pharms USA Inc, N...
|
|
Cite Document
1016 Exhibit: Ex 1016 Shinozaki et al, The Long Term Effect of Eicosapentaenoic A...
Document
IPR2022-00215, No. 1016 Exhibit - Ex 1016 Shinozaki et al, The Long Term Effect of Eicosapentaenoic Acid on Serum Levels of Lipoprotein a and Lipids in Patients with Vascular Disease, 22 J ...
|
|
Cite Document
1027 Exhibit: Ex 1027 Saito et al, Effects of EPA on Coronary Artery Disease in Hyp...
Document
IPR2022-00215, No. 1027 Exhibit - Ex 1027 Saito et al, Effects of EPA on Coronary Artery Disease in Hypercholesterolemic Patients with Multiple Risk Factors Sub Analysis of Primary Preventio...
|
|
Cite Document
1023 Exhibit: Ex 1023 Exhibit U to Plaintiffs First Amended Complaint,Ballantyne et...
Document
IPR2022-00215, No. 1023 Exhibit - Ex 1023 Exhibit U to Plaintiffs First Amended Complaint,Ballantyne et al, Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester AMR101 Therapy in Statin...
|
|
Cite Document
1035 Exhibit: Ex 1035 Declaration of C Rosebraugh from Amarin Pharma, Inc et al v...
Document
IPR2022-00215, No. 1035 Exhibit - Ex 1035 Declaration of C Rosebraugh from Amarin Pharma, Inc et al v US FDA et al, No 15 3588 SDNY (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
1024 Exhibit: Ex 1024 Exhibit V to Plaintiffs First Amended Complaint, Bhatt et al, C...
Document
IPR2022-00215, No. 1024 Exhibit - Ex 1024 Exhibit V to Plaintiffs First Amended Complaint, Bhatt et al, Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia, 3801 N Eng...
|
|
Cite Document
1021 Exhibit: Ex 1021 Plaintiffs Opposition to Motion to Dismiss from Amarin Pharm...
Document
IPR2022-00215, No. 1021 Exhibit - Ex 1021 Plaintiffs Opposition to Motion to Dismiss from Amarin Pharma, Inc et al vs Hikma Pharms USA Inc et al, CA No 20 1630 D Del (P.T.A.B. Nov. 30, 2021...
|
|
Cite Document
1025 Exhibit: Ex 1025 Amarin Response to US Patent Office re US Patent Applicati...
Document
IPR2022-00215, No. 1025 Exhibit - Ex 1025 Amarin Response to US Patent Office re US Patent Application No 17768,906 Aug 26, 2013 (P.T.A.B. Nov. 30, 2021)
|
|
Cite Document
